InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
18,927.60
(
-0.06%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
72.98
(
0.82%
)
Bitcoin
62,191.31
(
0.84%
)
Post# of 13962
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Namwons

Send PM Follow Ignore
Followers 0
Posts 5
Boards Moderated 0
Alias Born 07/10/2017

Namwons

Re: itsabouttime post# 1693

Thursday, 07/13/2017 6:19:32 AM

Thursday, July 13, 2017 6:19:32 AM

Post# of 13962
Good clue in the exhibit of the Pint:Cytovia agreement - ref "Combination Therapy". The only combination is the HDC/IL2 combination. IMNP/Cytovia are clearly building a position contingent on them getting the rights to IL2 which will enable them to create a combination product that would deliver them additional IP protection and rights to commercial product - as per the end of the Teper interview.

"The terms of the investment shall be defined in a separate agreement between PINT and CYTOVIA and such Equity Investment Agreement shall be executed once all conditions for the commercialization of the Product and the Combination Therapy in the LATAM region have been met."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up